Literature DB >> 29038309

Deletion of Protein Kinase D1 in Pancreatic β-Cells Impairs Insulin Secretion in High-Fat Diet-Fed Mice.

Valérie Bergeron1,2, Julien Ghislain1, Kevin Vivot1, Natalia Tamarina3, Louis H Philipson3, Jens Fielitz4,5,6, Vincent Poitout7,2.   

Abstract

Ββ-Cell adaptation to insulin resistance is necessary to maintain glucose homeostasis in obesity. Failure of this mechanism is a hallmark of type 2 diabetes (T2D). Hence, factors controlling functional β-cell compensation are potentially important targets for the treatment of T2D. Protein kinase D1 (PKD1) integrates diverse signals in the β-cell and plays a critical role in the control of insulin secretion. However, the role of β-cell PKD1 in glucose homeostasis in vivo is essentially unknown. Using β-cell-specific, inducible PKD1 knockout mice (βPKD1KO), we examined the role of β-cell PKD1 under basal conditions and during high-fat feeding. βPKD1KO mice under a chow diet presented no significant difference in glucose tolerance or insulin secretion compared with mice expressing the Cre transgene alone; however, when compared with wild-type mice, both groups developed glucose intolerance. Under a high-fat diet, deletion of PKD1 in β-cells worsened hyperglycemia, hyperinsulinemia, and glucose intolerance. This was accompanied by impaired glucose-induced insulin secretion both in vivo in hyperglycemic clamps and ex vivo in isolated islets from high-fat diet-fed βPKD1KO mice without changes in islet mass. This study demonstrates an essential role for PKD1 in the β-cell adaptive secretory response to high-fat feeding in mice.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29038309      PMCID: PMC5741145          DOI: 10.2337/db17-0982

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  25 in total

1.  Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice.

Authors:  G Pacini; K Thomaseth; B Ahrén
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-10       Impact factor: 4.310

2.  M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1.

Authors:  Kok Choi Kong; Adrian J Butcher; Phillip McWilliams; David Jones; Jürgen Wess; Fadi F Hamdan; Tim Werry; Elizabeth M Rosethorne; Steven J Charlton; Sarah E Munson; Hannah A Cragg; Alison D Smart; Andrew B Tobin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

3.  Loss of Lkb1 in adult beta cells increases beta cell mass and enhances glucose tolerance in mice.

Authors:  Accalia Fu; Andy Cheuk-Him Ng; Chantal Depatie; Nadeeja Wijesekara; Ying He; Gen-Sheng Wang; Nabeel Bardeesy; Fraser W Scott; Rhian M Touyz; Michael B Wheeler; Robert A Screaton
Journal:  Cell Metab       Date:  2009-10       Impact factor: 27.287

4.  A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice.

Authors:  A A Toye; J D Lippiat; P Proks; K Shimomura; L Bentley; A Hugill; V Mijat; M Goldsworthy; L Moir; A Haynes; J Quarterman; H C Freeman; F M Ashcroft; R D Cox
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

5.  PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice.

Authors:  José Iglesias; Sebastian Barg; David Vallois; Shawon Lahiri; Catherine Roger; Akadiri Yessoufou; Sylvain Pradevand; Angela McDonald; Claire Bonal; Frank Reimann; Fiona Gribble; Marie-Bernard Debril; Daniel Metzger; Pierre Chambon; Pedro Herrera; Guy A Rutter; Marc Prentki; Bernard Thorens; Walter Wahli
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

6.  Phenotypic Characterization of MIP-CreERT1Lphi Mice With Transgene-Driven Islet Expression of Human Growth Hormone.

Authors:  Daniel Oropeza; Nathalie Jouvet; Lionel Budry; Jonathan E Campbell; Khalil Bouyakdan; Julie Lacombe; Gabrielle Perron; Valerie Bergeron; Joshua C Neuman; Harpreet K Brar; Rachel J Fenske; Clemence Meunier; Sarah Sczelecki; Michelle E Kimple; Daniel J Drucker; Robert A Screaton; Vincent Poitout; Mathieu Ferron; Thierry Alquier; Jennifer L Estall
Journal:  Diabetes       Date:  2015-07-07       Impact factor: 9.461

Review 7.  Attention to Background Strain Is Essential for Metabolic Research: C57BL/6 and the International Knockout Mouse Consortium.

Authors:  Danielle A Fontaine; Dawn Belt Davis
Journal:  Diabetes       Date:  2016-01       Impact factor: 9.461

8.  Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis.

Authors:  Grzegorz Sumara; Ivan Formentini; Stephan Collins; Izabela Sumara; Renata Windak; Bernd Bodenmiller; Reshma Ramracheya; Dorothée Caille; Huiping Jiang; Kenneth A Platt; Paolo Meda; Rudolf Aebersold; Patrik Rorsman; Romeo Ricci
Journal:  Cell       Date:  2009-01-08       Impact factor: 41.582

9.  The BAR domain protein Arfaptin-1 controls secretory granule biogenesis at the trans-Golgi network.

Authors:  Helmuth Gehart; Alexander Goginashvili; Rainer Beck; Joëlle Morvan; Eric Erbs; Ivan Formentini; Maria Antonietta De Matteis; Yannick Schwab; Felix T Wieland; Romeo Ricci
Journal:  Dev Cell       Date:  2012-09-13       Impact factor: 12.270

10.  Characterization of mice expressing Ins1 gene promoter driven CreERT recombinase for conditional gene deletion in pancreatic β-cells.

Authors:  Natalia A Tamarina; Michael W Roe; Lh Philipson
Journal:  Islets       Date:  2014       Impact factor: 2.694

View more
  8 in total

Review 1.  Targeting lipid GPCRs to treat type 2 diabetes mellitus - progress and challenges.

Authors:  Julien Ghislain; Vincent Poitout
Journal:  Nat Rev Endocrinol       Date:  2021-01-25       Impact factor: 43.330

2.  Protein kinase D1 deletion in adipocytes enhances energy dissipation and protects against adiposity.

Authors:  Mona C Löffler; Alexander E Mayer; Jonathan Trujillo Viera; Angel Loza Valdes; Rabih El-Merahbi; Carsten P Ade; Till Karwen; Werner Schmitz; Anja Slotta; Manuela Erk; Sudha Janaki-Raman; Nuria Matesanz; Jorge L Torres; Miguel Marcos; Guadalupe Sabio; Martin Eilers; Almut Schulze; Grzegorz Sumara
Journal:  EMBO J       Date:  2018-11-02       Impact factor: 11.598

3.  A role for PKD1 in insulin secretion downstream of P2Y1 receptor activation in mouse and human islets.

Authors:  Shara Khan; Mourad Ferdaoussi; Austin Bautista; Valérie Bergeron; Nancy Smith; Vincent Poitout; Patrick E MacDonald
Journal:  Physiol Rep       Date:  2019-10

4.  Lysosomal degradation of newly formed insulin granules contributes to β cell failure in diabetes.

Authors:  Adrien Pasquier; Kevin Vivot; Eric Erbs; Coralie Spiegelhalter; Zhirong Zhang; Victor Aubert; Zengzhen Liu; Meryem Senkara; Elisa Maillard; Michel Pinget; Julie Kerr-Conte; François Pattou; Gilbert Marciniak; Axel Ganzhorn; Paolo Ronchi; Nicole L Schieber; Yannick Schwab; Paul Saftig; Alexander Goginashvili; Romeo Ricci
Journal:  Nat Commun       Date:  2019-07-25       Impact factor: 14.919

Review 5.  Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review.

Authors:  Katarzyna Kolczynska; Angel Loza-Valdes; Izabela Hawro; Grzegorz Sumara
Journal:  Lipids Health Dis       Date:  2020-05-28       Impact factor: 3.876

6.  Targeted deletion of Insm2 in mice result in reduced insulin secretion and glucose intolerance.

Authors:  Lin Wang; Zhong Sheng Sun; Bingwu Xiang; Chi-Ju Wei; Yan Wang; Kevin Sun; Guanjie Chen; Michael S Lan; Gilberto N Carmona; Abner L Notkins; Tao Cai
Journal:  J Transl Med       Date:  2018-10-25       Impact factor: 5.531

Review 7.  Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases.

Authors:  Xuejing Zhang; Jaclyn Connelly; Yapeng Chao; Qiming Jane Wang
Journal:  Biomolecules       Date:  2021-03-23

Review 8.  Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy.

Authors:  Die Lv; Hongli Chen; Yun Feng; Bomiao Cui; Yingzhu Kang; Ping Zhang; Min Luo; Jiao Chen
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.